PUBLISHER: 360iResearch | PRODUCT CODE: 1598432
PUBLISHER: 360iResearch | PRODUCT CODE: 1598432
Thyroid Cancer Diagnostics Market by Type (Follicular Carcinoma, Papillary Carcinoma), Technique (Biopsy, Blood Test, Imaging), End-user - Global Forecast 2025-2030
The Thyroid Cancer Diagnostics Market was valued at USD 244.88 million in 2023, expected to reach USD 257.58 million in 2024, and is projected to grow at a CAGR of 5.67%, to USD 360.33 million by 2030.
Thyroid cancer diagnostics encompass a range of medical tools and methodologies to detect and diagnose thyroid cancer, a malignancy affecting the thyroid gland. This market's scope includes diagnostic imaging technologies such as ultrasound, fine needle aspiration biopsy, blood tests, and molecular testing aimed at identifying cancerous cells or genetic markers. The necessity stems from the rising incidence of thyroid cancer globally, driven by factors like increased use of imaging techniques and heightened awareness. Applications are manifold, including aiding in early-stage detection, monitoring recurrence, and guiding treatment plans across hospitals, diagnostic laboratories, and cancer research centers.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 244.88 million |
| Estimated Year [2024] | USD 257.58 million |
| Forecast Year [2030] | USD 360.33 million |
| CAGR (%) | 5.67% |
Key growth factors include technological advancements in diagnostic tools, a growing geriatric population, and the increasing prevalence of thyroid disorders. The development of non-invasive, cost-effective diagnostic techniques offers a significant potential opportunity, especially in emerging markets with expanding healthcare infrastructure. Furthermore, collaborations between technology firms and medical institutions to enhance diagnostic accuracy present strategic avenues for growth. Nevertheless, the high cost of advanced diagnostic procedures and equipment, coupled with stringent regulatory frameworks, pose challenges in market expansion.
Future innovation in the field can focus on developing novel biomarkers for early detection and progression monitoring, enhancing AI-driven diagnostic platforms, and improving accessibility through telemedicine and at-home testing solutions. By investing in R&D for personalized medicine and precision diagnostics, businesses can better cater to the diverse needs of patients with varying genetic backgrounds. The thyroid cancer diagnostics market is competitive yet dynamic, with opportunities in digital health and the integration of big data analytics to improve predictive diagnostics. To effectively navigate this market, companies should prioritize partnerships with healthcare providers, focus on cost-reduction strategies, and foster awareness on the significance of early diagnosis to expand their reach and impact.
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Thyroid Cancer Diagnostics Market
The Thyroid Cancer Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- Growing prevalence of thyroid cancer cases across the globe
- Increasing focus on early diagnosis and treatment
- Private organizations increasing cancer screening programs
- Market Restraints
- High cost of diagnosis and possible side effects
- Market Opportunities
- Thyroid cancer detection R&D investment by industry players
- Advancements in cancer diagnostics technology
- Market Challenges
- Shortage of medical professionals
Porter's Five Forces: A Strategic Tool for Navigating the Thyroid Cancer Diagnostics Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Thyroid Cancer Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Thyroid Cancer Diagnostics Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Thyroid Cancer Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Thyroid Cancer Diagnostics Market
A detailed market share analysis in the Thyroid Cancer Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Thyroid Cancer Diagnostics Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Thyroid Cancer Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the Thyroid Cancer Diagnostics Market
A strategic analysis of the Thyroid Cancer Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the Thyroid Cancer Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Biocare Medical LLC, Biocartis Group NV, bioMerieux SA, EverlyWell, Inc., F. Hoffmann-La Roche AG, Fortis Healthcare Ltd, Illumina, Inc., Koninklijke Philips N.V., Leica Biosystems Nussloch GmbH, Merck KGaA, NeoGenomics Laboratories, Inc., Siemens Healthcare GmbH, and Thermo Fisher Scientific, Inc..
Market Segmentation & Coverage
This research report categorizes the Thyroid Cancer Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Type, market is studied across Follicular Carcinoma and Papillary Carcinoma.
- Based on Technique, market is studied across Biopsy, Blood Test, and Imaging.
- Based on End-user, market is studied across Cancer Diagnostic Centers, Hospital Laboratories, and Research Institutes.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing prevalence of thyroid cancer cases across the globe
- 5.1.1.2. Increasing focus on early diagnosis and treatment
- 5.1.1.3. Private organizations increasing cancer screening programs
- 5.1.2. Restraints
- 5.1.2.1. High cost of diagnosis and possible side effects
- 5.1.3. Opportunities
- 5.1.3.1. Thyroid cancer detection R&D investment by industry players
- 5.1.3.2. Advancements in cancer diagnostics technology
- 5.1.4. Challenges
- 5.1.4.1. Shortage of medical professionals
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. Thyroid Cancer Diagnostics Market, by Type
- 6.1. Introduction
- 6.2. Follicular Carcinoma
- 6.3. Papillary Carcinoma
7. Thyroid Cancer Diagnostics Market, by Technique
- 7.1. Introduction
- 7.2. Biopsy
- 7.3. Blood Test
- 7.4. Imaging
8. Thyroid Cancer Diagnostics Market, by End-user
- 8.1. Introduction
- 8.2. Cancer Diagnostic Centers
- 8.3. Hospital Laboratories
- 8.4. Research Institutes
9. Americas Thyroid Cancer Diagnostics Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
10. Asia-Pacific Thyroid Cancer Diagnostics Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
11. Europe, Middle East & Africa Thyroid Cancer Diagnostics Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
12. Competitive Landscape
- 12.1. Market Share Analysis, 2023
- 12.2. FPNV Positioning Matrix, 2023
- 12.3. Competitive Scenario Analysis
- 12.4. Strategy Analysis & Recommendation
Companies Mentioned
- 1. Agilent Technologies, Inc.
- 2. Bio-Rad Laboratories, Inc.
- 3. Biocare Medical LLC
- 4. Biocartis Group NV
- 5. bioMerieux SA
- 6. EverlyWell, Inc.
- 7. F. Hoffmann-La Roche AG
- 8. Fortis Healthcare Ltd
- 9. Illumina, Inc.
- 10. Koninklijke Philips N.V.
- 11. Leica Biosystems Nussloch GmbH
- 12. Merck KGaA
- 13. NeoGenomics Laboratories, Inc.
- 14. Siemens Healthcare GmbH
- 15. Thermo Fisher Scientific, Inc.
LIST OF FIGURES
- FIGURE 1. THYROID CANCER DIAGNOSTICS MARKET RESEARCH PROCESS
- FIGURE 2. THYROID CANCER DIAGNOSTICS MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 5. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 7. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 8. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
- FIGURE 9. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 10. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 11. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 12. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 13. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 14. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 15. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 16. ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 17. ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 20. THYROID CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 21. THYROID CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. THYROID CANCER DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 6. THYROID CANCER DIAGNOSTICS MARKET DYNAMICS
- TABLE 7. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 8. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY FOLLICULAR CARCINOMA, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY PAPILLARY CARCINOMA, BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 11. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 12. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, BY REGION, 2018-2030 (USD MILLION)
- TABLE 13. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2018-2030 (USD MILLION)
- TABLE 14. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 15. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY CANCER DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 16. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 17. GLOBAL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 18. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 19. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 20. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 21. AMERICAS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 22. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 23. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 24. ARGENTINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 25. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 26. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 27. BRAZIL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 28. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 29. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 30. CANADA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 31. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 32. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 33. MEXICO THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 34. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 35. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 36. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 37. UNITED STATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 38. ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 39. ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 40. ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 41. ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 42. AUSTRALIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 43. AUSTRALIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 44. AUSTRALIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 45. CHINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 46. CHINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 47. CHINA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 48. INDIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 49. INDIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 50. INDIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 51. INDONESIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 52. INDONESIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 53. INDONESIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 54. JAPAN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 55. JAPAN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 56. JAPAN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 57. MALAYSIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 58. MALAYSIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 59. MALAYSIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 60. PHILIPPINES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 61. PHILIPPINES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 62. PHILIPPINES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 63. SINGAPORE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 64. SINGAPORE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 65. SINGAPORE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 66. SOUTH KOREA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 67. SOUTH KOREA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 68. SOUTH KOREA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 69. TAIWAN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 70. TAIWAN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 71. TAIWAN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 72. THAILAND THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 73. THAILAND THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 74. THAILAND THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 75. VIETNAM THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 76. VIETNAM THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 77. VIETNAM THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 78. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 79. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 80. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 81. EUROPE, MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 82. DENMARK THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 83. DENMARK THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 84. DENMARK THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 85. EGYPT THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 86. EGYPT THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 87. EGYPT THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 88. FINLAND THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 89. FINLAND THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 90. FINLAND THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 91. FRANCE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 92. FRANCE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 93. FRANCE THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 94. GERMANY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 95. GERMANY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 96. GERMANY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 97. ISRAEL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 98. ISRAEL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 99. ISRAEL THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 100. ITALY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 101. ITALY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 102. ITALY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 103. NETHERLANDS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 104. NETHERLANDS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 105. NETHERLANDS THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 106. NIGERIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 107. NIGERIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 108. NIGERIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 109. NORWAY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 110. NORWAY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 111. NORWAY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 112. POLAND THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 113. POLAND THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 114. POLAND THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 115. QATAR THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 116. QATAR THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 117. QATAR THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 118. RUSSIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 119. RUSSIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 120. RUSSIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 121. SAUDI ARABIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 122. SAUDI ARABIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 123. SAUDI ARABIA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 124. SOUTH AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 125. SOUTH AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 126. SOUTH AFRICA THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 127. SPAIN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 128. SPAIN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 129. SPAIN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 130. SWEDEN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 131. SWEDEN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 132. SWEDEN THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 133. SWITZERLAND THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 134. SWITZERLAND THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 135. SWITZERLAND THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 136. TURKEY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 137. TURKEY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 138. TURKEY THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 139. UNITED ARAB EMIRATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 140. UNITED ARAB EMIRATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 141. UNITED ARAB EMIRATES THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 142. UNITED KINGDOM THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 143. UNITED KINGDOM THYROID CANCER DIAGNOSTICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
- TABLE 144. UNITED KINGDOM THYROID CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 145. THYROID CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 146. THYROID CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
